Home China's AI-Powered Personalized Cancer Vaccine XH001 Enters Clinical Trials

China's AI-Powered Personalized Cancer Vaccine XH001 Enters Clinical Trials

May 24, 2026 23:59 CST Updated May 25, 01:56